Interim Management Statement Q3 2024 16 August 2024

New Post Public Reply Private Reply Replies (0) Message Board
News
38
Interim Management Statement Q3 2024

16 August 2024

HARGREAVE HALE AIM VCT PLC (the “ Company ”)

Interim Management Statement

Q3 2024

Introduction

This interim management statement covers the third quarter of the 2023/24 financial year, 1 April 2024 to 30 June 2024. Investment performance measures contained in this report are calculated on a pence per share basis and include realised and unrealised gains and losses.

Overview

During the quarter UK Inflation (Consumer Price Index) returned to the Bank of England’s target of 2%, drawing to a close a 3-year inflation cycle that was very difficult for UK consumers and households and bringing with it hope that we can finally move on from the cost-of-living crisis. With inflation now on target and the Bank of England starting to reduce interest rates, many companies and households can look forward to reduced borrowing costs.

There has been considerable discussion about when and to what extent central banks should ease interest rates with market pricing moving with the release of each related data point. Within the period, the dominant trend was one of sticky inflation, either in the headline number or subsets of it. Within the UK, wage inflation and services inflation remained at elevated levels whilst inflation in food and energy abated relatively quickly. Post period end, the Bank of England cut interest rates by 25 basis points to 5.0%. Currently, the markets are pricing in another two cuts by the calendar year end.

Much of the current thinking in markets has developed post period end. In the US, July brought with it a noticeable rotation away from the US mega caps in favour of smaller companies. Compositional differences in the UK markets limit the scope for a similar theme; however, there has been a noticeable pick up in interest in UK equities and, including small companies, since the UK March GDP print beat expectations and UK inflation returned to target.

Recent economic data releases have suggested that the US economy may be cooling more rapidly than many had expected, leading to a sharp adjustment in the market outlook for US interest rates and contributing to a significant repricing of a range of asset classes and a notable spike in volatility.

We have frequently flagged the impact of sustained fund outflows on UK equities. Although the fund flow data in May remained very poor, we and other small cap managers have noted a significant improvement in the flow dynamic within UK small companies. It is too early to say that the market has turned decisively; however, it feels like the direction of travel may be about to change. Several prominent strategists have turned more positive on UK equities. Many, not least of all private equity and overseas trade buyers, recognise that many UK small companies offer good long term growth at attractive prices. We would agree and hope that asset allocators start to recognise this too, allowing companies to recover in value and put an end to the constant loss of opportunity to foreign ownership. In this regard, the change of Government may help. Suddenly, the UK political framework looks stable and attractive compared to several other G7 economies.

The improving mood is showing up in GDP beats, improving business confidence, higher UK consumer confidence, increased retail sales (not withstanding the impact of poor weather in June) and stronger housing and construction markets. Forward looking data such as the UK Purchasing Managers’ Indices are all positive. We have observed that more portfolio companies are reporting that they are trading at least in line with expectations.

To date, the more positive sentiment within the UK market is yet to manifest in more companies committing to initial public offerings on AIM. Possibly for the first time in the nearly 20 years we have been running the VCT, we were unable to deploy any capital into qualifying companies within a quarter. We remain ready and very keen to invest in exciting UK growth companies and are pleased to report that capital deployment for the current quarter is ahead of budget.

After a period of consolidation at the start of 2024, AIM performance was once again positive, with the AIM All-Share Index returning 2.8% in the 3 months to June 2024. Investors have continued to show a preference for investment in larger companies; however, there is some evidence to suggest that trend is starting to reverse and may continue to do so as interest rates start to fall. We are cautiously optimistic.

Performance

In the 3 months to 30 June 2024, the unaudited NAV per share increased by +1.12 pence from 43.64 pence to 44.76 pence cum dividend (42.26 pence ex-dividend), allowing for the 2.50p dividend that went ex-dividend in the quarter, giving a total return of +2.57%.

The qualifying investments made a gain of 0.79 pence per share whilst the non-qualifying investments made a gain of 0.26 pence per share. The adjusting balance was the net of running costs and investment income.

Qualifying Investments

Zoo Digital (+82.9%, +0.35 pence per share) issued a positive trading update in May, reporting a continuing recovery in demand following the conclusion of the Hollywood strikes. Net cash was also better than anticipated. Following a very difficult period, revenues are expected to recover from $40m in FY24 to $65m in FY25. There is scope for further upside as the company returns to growth and profitability.

Kidly (+460.8%, +0.28 pence per share) saw a recovery in value as the company agreed a new financing package.

The Property Franchise Group (+35.9%, +0.26 pence per share) issued FY23 results and signalled that FY24 had started well for the newly combined businesses with the UK letting market remaining strong, sales improving from a low base and the integration of Belvoir progressing positively. The company subsequently announced the earnings accretive acquisition of The Guild of Property Professionals and Fine & Country for £20m.

Itaconix (-42.9%, -0.35 pence per share) reported the termination of a supply contract with its largest client after failing to agree on pricing, resulting in a large downgrade to revenues and an $0.8m reduction in EBITDA. The company plans to focus on higher margin opportunities and the subsequent May trading update noted improving gross profit margins.

Disappointingly, Surface Transforms (-86.7%, -0.21 pence per share) reported further production issues. Q1 revenues were below internal targets, resulting in a reduction to 2024 revenue guidance. In May, the company raised £8.5m of additional working capital and capex funding in a deeply discounted fundraise that was not VCT qualifying and very dilutive to existing shareholders.

Engage XR (-42.1%, -0.19 pence per share) appointed a new USA-based non-Executive Chairman, bringing extensive experience from his roles at Mindbridge.ai and Kyriba. In April, the company reported FY23 results with revenues of €3.7m (-5% YOY), and an EBITDA loss of €4.0m. The balance sheet remains strong and the company maintains that it is funded to breakeven.

Non-Qualifying Investments

The IFSL Marlborough UK Micro-Cap Growth Fund (+0.29 pence per share) and IFSL Marlborough Special Situations Fund (0.19 pence per share) performed well over the period as the dynamics within the UK small cap equity market improved. This was partially offset by the VCT’s direct equity holdings (-0.19 pence per share), driven by some weakness in consumer exposed stocks. We have been, and remain, positive on UK Smaller Companies and expect a broad-based recovery in value. As a result, we have favoured higher allocations to the two Marlborough Funds over adding direct equity investments in larger companies. The direct equity part of the non-qualifying portfolio remains biased towards dividend yielding stocks within the FTSE 350.

Portfolio structure

The VCT is comfortably above the HMRC defined investment test and ended the period at 94.74% invested as measured by the HMRC investment test. By market value, the weighting to qualifying investments decreased from 53.1% to 52.3%.

There were no new qualifying investments during the period, and the market remains very subdued with just one VCT qualifying IPO 1 within the last 12 months. We are hopeful that improving market conditions will help reverse the trend.

There were no substantial changes to the allocation to the two IFSL Marlborough Funds, non-qualifying equities, fixed income or cash, which respectively represented 12.5%, 7.5%, 13.5% and 13.8% of net assets.

The HMRC investment tests are set out in Chapter 3 of Part 6 Income Tax Act 2007, which should be read in conjunction with this interim management statement. Funds raised by VCTs are first included in the investment tests from the start of the accounting period containing the third anniversary of the date on which the funds were raised. Therefore, the allocation of qualifying investments as defined by the legislation can be different to the portfolio weighting as measured by market value relative to the net assets of the VCT.

Share Buy Backs & Discount Control

2,610,661 shares were acquired in the quarter at an average price of 42.26 pence per share. The share price decreased from 42.20p to 40.00p within the quarter and traded at a discount of 5.35% following the publication of the 30 June 2024 NAV on 4 July 2024.

Post Period End

The unaudited NAV per share decreased from 42.26 pence to 42.12 pence as at 9 August 2024, a decrease of 0.33%. The FTSE AIM All-Share index increased by 0.24%.

END

For further information please contact:

Oliver Bedford, Canaccord Genuity Asset Management

Tel: 020 7523 4837

LEI: 213800LRYA19A69SIT31        


1 A second company sought funding at IPO but failed to attract any capital from VCTs.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 71

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 92

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
STVN's GLP-1 Fumble Sparks Shareholder Scrutiny

Updated Category News Views 35

The Storm Hits Stevanato: GLP-1 Blues Well, ain't this a fine pickle for Stevanato Group S.p.A. (NYSE:STVN). November 3, 2026, turned into quite the ride for those holding STVN shares. A tough third-quarter report dropped like a ton of bricks, driving the shares down after they coughed up a lower outlook for GLP-1 volumes in 2027. If you've been in the game long enough,...

Continue Reading
Tamagotchi Turns 30: Roblox Event Connects Worlds

Updated Category News Views 17

A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...

Continue Reading
ROBOTWORLD 2026: AI Reshapes Industrial Horizons

Updated Category News Views 48

A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...

Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog

Updated Category News Views 94

The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 0

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 101

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Compass Faces Securities Fraud Suit: Deadline Looms

Updated Category News Views 45

Compass's Legal Rumble: Shareholders Take Note You know there’s trouble when a firm’s every effort at glassy-eyed optimism is slapped with a lawsuit. We've seen this song and dance far too often, and now Compass, Inc. (NYSE: COMP) takes center stage. Schall, Brown & Schwartz LLP is rallying the troops for a knock-down-drag-out class action lawsuit, accusing Compass of...

Continue Reading
s of Cautious Optimism - Continue Reading" aria-label="Continue reading: Farmer Sentiment Rises, Hints of Cautious Optimism"> Continue Reading
More News Articles

Top 5 Most Recently Viewed Articles

Analyzing Meta Platforms: A Deep Dive into Finances and Growth

Updated Category News Views 624

Examining Meta Platforms Against Industry Rivals In today’s fast-paced and competitive business environment, investors and industry analysts must perform thorough evaluations of companies. This article explores Meta Platforms (NASDAQ: META) in comparison to its key competitors within the Interactive Media & Services space. By analyzing significant financial metrics,...

Continue Reading
Key Stocks to Monitor for Imminent Market Movements

Updated Category News Views 241

Stocks Captivating Investors Ahead of Market Open As U.S. stock futures exhibit a downward trend this Tuesday morning, several companies are poised to attract the attention of investors looking for opportunities in the market. Below, we explore key stocks including Home Depot Inc., Medtronic PLC, and others making headlines today. Home Depot's Earnings Forecast Home Depot...

Continue Reading
CollPlant Unveils Q2 2025 Financial Results and Growth Plans

Updated Category News Views 139

CollPlant Unveils Q2 2025 Financial Results and Growth Plans CollPlant Biotechnologies, a pioneering name in regenerative medicine, has recently disclosed its financial results for the second quarter of 2025, showcasing significant progress and updates on its corporate initiatives. - Sales for rhCollagen and bioinks are set for a boost following enhancements in leadership...

Continue Reading
Virtual Nursing Growth: Insights Into Provider Adoption Trends

Updated Category News Views 179

Survey Reveals Virtual Nursing Adoption Trends A recent report highlights the evolving landscape of virtual nursing, emphasizing the significant strides made by healthcare providers in enhancing care delivery. Despite these advancements, many organizations remain at the initial stages of implementation. The State of Inpatient Virtual Care The findings from this...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 109

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading